Skip to main content
    • Aa
    • Aa

The discovery and role of ADAM33, a new candidate gene for asthma

  • John W. Holloway (a1), Tim P. Keith (a2), Donna E. Davies (a3), Robert Powell (a3), Hans-Michael Haitchi (a3) and Stephen T. Holgate (a3)...

Asthma is a complex disorder in which major genetic and environmental factors interact to initiate the disease and propagate it as a chronic relapsing disorder. Until recently, genetic factors implicated in the disease pathogenesis have been restricted to variants in known molecules involved in the inflammatory or remodelling pathways. This review discusses evidence for a new susceptibility gene for asthma, ADAM33, which was identified by positional cloning and shown to be selectively expressed in mesenchymal but not immune or inflammatory cells. ADAM33 belongs to a family of membrane–anchored metalloproteinases that also have fusagenic, adhesion and intracellular signalling properties. ADAM33 might play a key role in predisposing to the reduced lung function characteristic of asthma, possibly by influencing airway wall remodelling.

Corresponding author
Allergy and Inflammation Research, Infection, Inflammation and Repair Research Division, School of Medicine, University of Southampton, D level Centre Block (MP810), Southampton General Hospital, Southampton, SO16 6YD, UK. Tel: +44 (0)23 8079 6960; Fax: +44 (0)23 8070 1771E-mail:
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *